chrisvoncsefalvay/vaers-outcomes huggingface dataset:
very sore arm for 2 to 3 days this time; Initial information received on 08-Nov-2021 regarding an unsolicited valid non-serious case from a consumer/non-health care professional via social media.  This case involves a patient (unknown age and gender) who had very sore arm for 2 to 3 days (pain in extremity), after receiving INFLUENZA VACCINE.  The patient's past vaccination(s) included Influenza vaccine and coronavirus disease 2019 (COVID-19) vaccine.  It was unknown if the patient had any other medical history, concomitant disease or risk factor.   Medical treatment(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date were not reported) via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious very sore arm for 2 to 3 days this time (pain in extremity) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "why hidden didn't say anything bad, other years shot was not as sore in arm, i get stronger dose senior, i don't due shots well don't have fat arms, covid shots were less pain. got mine a week ago, very sore arm for 2-3 days this time."  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were laboratory data/results available.   It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was unknown for the reported event.  There will be no information available on the batch number for this case.
Patient reported to monitoring RN that her throat "burned" and had the feeling of heartburn. No other symptoms reported. Nurse took vital signs at 1700, and vital signs were as follows:  pulse 71 BPM, 112/62 mmHg, respirations 20 BPM, and oxygen saturation 96%. RN practiced therapeutic communication and relaxation techniques.  At 1708, patient reported that she the symptom had resolved, and this may be due to her "burping." RN provided education on what to do if adverse reactions occurs, and released home.
Pt sustained scratch to Rt hand 4-4-08. Received Tdap upper (L) arm. Pt seen by doctor 4-10-08 reporting (L) arm soreness and swelling injection site. Received Keflex qid. On 4-11-08, pt had severe chest discomfort, syncope, and shortness of breath. Was airlifted to hospital.  04/28/2008 MR received for DOS 4/11-12/2008 with D/C DX: Substernal chest heaviness/unstable angina pectoris: Documented normal coronary arteries per heart cath. L arm swelling: S/P TDaP injection 2 weeks ago.  Suspect inflammatory reaction treated with Solumedrol. Hx of cerebral blood flow abnormality with subsequent Chiari procedure 4 yrs ago.  Hx of carcinoma of the breast with R mastectomy.  Exogenous obesity.  Hyperlipidemia.  Negative gallbladder sonogram.  Negative bilateral Doppler study of lower extremities. Pt transported to ER with substernal chest discomfort, weakness and near syncope. Pt was on abx x 1 day for swelling and pain in the injected arm. Cardiac w/u (-). D/C in stable condition.
Information has been received from a physician concerning a 2 year old male who on 24-JUN-2008 was vaccinated with VAQTA vaccine, 0.5 ml, IM (lot # 659186/1258U). Concomitant therapy included diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid and poliovirus vaccine. On 24-JUN-2008 the patient experienced low grade fever and redness and swelling that progressed to blisters at the injection site (thigh) after receiving his first dose of VAQTA. At this time, it was reported that the patient has not recovered. Unspecified medical attention was sought. No product quality complaint. Additional information has been requested.
R arm swollen 1d after DTaP given. R arm was red and swollen. No fever, pain or tenderness. Swelling started decreasing in 24-48 hours.
Bright reddish pink circleon her arm; Few pimples; Blemishes; This spontaneous case was reported by a consumer and describes the occurrence of   in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), VALSARTAN, SIMVASTATIN and VITAMINS NOS for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient consulted an HCP and was advised that the symptoms will eventually resolve hence she was not prescribed to take any medication.
diagnoses of Bells palsy; This is a spontaneous report from a contactable healthcare professional (patient). A 50-year-old patient of an unspecified gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot Number: EP6955) via an unspecified route of administration, administered in Arm Left, at the age of 50-year-old, on 13Apr2021, as SINGLE DOSE for covid-19 immunisation.  Medical history included mitral valve repair in 2017 (4 years ago). Concomitant medications were not reported. The patient was not diagnosed with COVID and did not receive any other vaccine four weeks prior. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot Number: EP6955) via an unspecified route of administration, administered in Arm Left, at the age of 50-year-old, on 23Mar2021 09:45 AM, as SINGLE DOSE for covid-19 immunisation. On 13Apr2021, the patient was brought to the ER and there the patient was diagnosed with Bells Palsy. The event resulted in physician office visit and caused disability/ permanent damage. Therapeutic measures taken in response to the event included administration of doxycycline and prednisone. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on an unspecified date. Outcome of the event was not recovered.; Sender's Comments: Based on the reasonable temporal association and considering the known safety profile of COVID19 vaccine, BNT162B2, the Company cannot completely exclude the possible causality between the reported Bells Palsy and the administration of the suspect.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.
felt tired afterwards; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (felt tired afterwards) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Flu: Flu shot. Past adverse reactions to the above products included No adverse event with Flu shot.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (felt tired afterwards). At the time of the report, FATIGUE (felt tired afterwards) outcome was unknown.            Concomitant drugs were not reported. Treatment medications were not provided. The patient received flu shot 14 days prior to booster dose.   This case was linked to MOD-2021-364285 (Patient Link).
1 hour after 3rd dose of TRUMEMBA vaccine patient developed uncontrollable shivering. Prednisone 60 mg oral given.
Swollen, hot, painful injection site. Violent chills for four hours. Migraine for 48 hours. Diarrhea. Phone conversation with physician, told me to wait it out. There is no antidote. Told me not to get flu shots in the future. Pharmacist said the same thing. This was worse than any flu I've ever had!
R. arm swelled to elbow, very red like a sunburn. 50 cent size hives on R. arm, cold sweats, chills for 2 days.
On 19DEC89 pt devel joint pain in knees later joint pain in shoulders prevented pt from sleeping; 3 days later wrist pain prevented fr writing; skin irritation & ringing in ears; Meds gave upset stomach, numbness & tingling;
This spontaneous report as received from a Certified Medical Assistant refers to 54 years old female with rheumatoid arthritis and not pregnant at the time of reporting. On 15-DEC-2010, at age of 53, the patient was vaccinated with ZOSTAVAX subcutaneously (dose, lot number and expiration date were not reported). Concomitant therapies included XANAX, ZANTAC, HCTZ, nadolol and FLONASE. In August 2011 the patient developed shingles, information on location or severity was not reported. On 19-JUL-2012 the patient experienced another outbreak of shingles on her buttocks and down her right leg. On 16-OCT-2012 physician prescribed to the patient VALTREX, daily for unspecified period of time. Healthcare worker reported that the second case of shingles was incapacitating to the patient as the patient was a bus driver and shingles were on the buttocks making it impossible to sit. Patient sought unspecified medical attention. The relatedness between shingles and ZOSTAVAX was not provided. The outcome of shingles was unknown. Additional information has been requested.
Narrative: Patient is a 43 yo male patient with PMH of PTSD who received the first dose of the Moderna COVID-19 vaccine on 3/4/21. Patient received his second dose on 4/1/21. Patient received both vaccinations in left deltoid. On 4/2/21, patient reported body aches, nausea, and fever with temperature 101-103 F. Body aches with pain score 7/10.
A small rash appeared on my arms Saturday afternoon May 15. It spread to my ears and head. On Sunday morning, the rash was gone. By Sunday evening, the rash had reappeared on my arms, stomach, and waistline. Through Sunday night, I developed full body hives, including my head and going down to my ankles.  I took Benadryl to help soothe the itching. The rash was still present Monday morning, but faded as the day progressed after taking Allegra and applying hydrocortisone cream. Tuesday morning the full body rash was present again, but disappeared as the day progressed.
diarrhea; Nausea; Vomiting; arm of injection was sore and booming; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), INJECTION SITE PAIN (arm of injection was sore and booming), NAUSEA (Nausea) and VOMITING (Vomiting) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025120A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced INJECTION SITE PAIN (arm of injection was sore and booming). On 29-Jan-2021, the patient experienced DIARRHOEA (diarrhea), NAUSEA (Nausea) and VOMITING (Vomiting). The patient was treated with PARACETAMOL (TYLENOL) for Injection site pain, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), INJECTION SITE PAIN (arm of injection was sore and booming), NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Pt c/o numbness and muscle weakness in legs since hysterectomy 2 weeks ago. States is unable to stand or bear any weight. Today is unable to use hands and legs are cool to the touch.
petechiae like rash on the breast; itching; fever of 100F; broke out into rash all over chest, stomach, back, waist at the back, and under breast; This spontaneous case was reported by a consumer and describes the occurrence of PETECHIAE (petechiae like rash on the breast), PRURITUS (itching), PYREXIA (fever of 100F) and RASH (broke out into rash all over chest, stomach, back, waist at the back, and under breast) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     Concomitant products included DILTIAZEM HCL, IRBESARTAN and HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE HCTZ) for an unknown indication.   On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced PETECHIAE (petechiae like rash on the breast), PRURITUS (itching), PYREXIA (fever of 100F) and RASH (broke out into rash all over chest, stomach, back, waist at the back, and under breast). On 08-Feb-2021, PETECHIAE (petechiae like rash on the breast), PYREXIA (fever of 100F) and RASH (broke out into rash all over chest, stomach, back, waist at the back, and under breast) had resolved. At the time of the report, PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided.
delirium,  diarrhea On 02/13/2021 pt entered physician office for incorrect appt date and found to disoriented.  Transferred to Hospital.  Pt had in-pt stay until 02/13/2021.  Pt discharged to son's care as she was unable to care for herself indepently.  As of 02/23/2021 pt has still not returned to baseline.
I had the shot 7 weeks ago and am still suffering debilitating effects. The shot was administered too low and has caused nerve damage. I have pins and needles in my hand, limited arm motion, pain in my shoulder, difficulty sleeping due to pain, I cannot do normal everyday things like put on a coat properly due to limited movement. Constant ache in my shoulder and muscle. Burning sensation running down my arm especially after teaching all day.
Pneumonia and Respiratory Failure after Pneumonia Vaccine; Respiratory Failure; Pneumonia and Respiratory Failure after Pneumonia Vaccine; This is a spontaneous report from a contactable nurse (patient).  A female patient of an unspecified age received pneumococcal 13-val conjugate vaccine (diphtheria crm197 protein), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced pneumonia and respiratory failure after pneumonia vaccine on an unspecified date and states that she almost died. The patient was hospitalized due to the events for 42 days (6 weeks). The outcome of the events was unknown.  Pfizer is a marketing authorization holder of pneumococcal 13-val conjugate vaccine (diphtheria crm197 protein) in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of pneumococcal 13-val conjugate vaccine (diphtheria crm197 protein) has submitted the same report to the regulatory authorities.  Information about batch/lot number requested; Sender's Comments: A possible contributory role of the suspect products cannot be excluded for the reported events pneumonia and associated respiratory failure  based on the known safety profile and temporal association
RECEIVED HALF DOSE FOR THEIR BOOSTER DOSE; OFF LABEL USE; This spontaneous report received from a health care professional concerned a 31 year old female of unspecified race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously vaccinated with covid-19 vaccine ad26. cov2. s unspecified manufacturer (suspension for injection, route of admin, and batch number were not reported) dose was not reported for prophylactic vaccination (dose number in series 1). No adverse events were reported following administration of covid-19 vaccine ad26. cov2. s (dose number in series 1) The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 211A21A, expiry: 28-NOV-2021) 0.25 ml, 01 total administered on 28-NOV-2021 for prophylactic vaccination (dose number in series 2).  On 28-NOV-2021, the patient received a half dose of the Janssen Covid-19 vaccine for their booster dose (Vaccine underdose and off label use) (dose number in series 2). As described by reporter, HCP (health care provider) (from public health dept) stated that there were 33 patients who received half doses (0.25ml (milliliter)) for their booster or 3rd dose a few days ago. Most of them were patients from Texas. HCP stated that something was printed and disseminated that said to administer .25ml. HCP was not sure where that information came from. Stated it was over the holidays so people could have thought that info changed and staff was just not made aware. HCP did not think it had been reported yet through VAERS. HCP thought that the vendor will file the report with VAERS, not public health department. HCP stated that they figured it out after the event because they could not figure out how so many doses were given. They were looking for a discrepancy in the number of vials perhaps, but then realized that half doses were given. HCP consented to being contacted, but stated that she may not be the best person to contact. If she had an alternate contact she would provide it to whomever reached out to her. The reporter went on to report that HCP stated that Spartan is the vendor. At the time of the discussion they were both teaming up together to gather information and they may have called to report these events as well, so HCP warned to be mindful of possible duplicate reports.(dose number in series 2) The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of received half dose for their booster dose and off label use was unknown. This report was non-serious. This case, from the same reporter is linked to 20211202250, 20211201046, 20211202193, 20211201082, 20211201228, 20211201168, 20211200752, 20211201351, 20211200994, 20211201450, 20211202469, 20211165041, 20211202379, 20211202371, 20211202246, 20211202207, 20211201443, 20211201392, 20211201362, 20211201304, 20211201179, 20211200769, 20211200723, 20211200717, 20211200675 and 20211165041.
A parent, called the HD in regards to her son who has been sick for three weeks since he received vaccines on 9/13/18.  Patient received Tdap, HPV, MCV4, and Hep A that day.  Per mom, he has been running a low grade fever, had an upset stomach, and been fatigued for the last three weeks.  She also states that the following night after the vaccines, he had a welt the size of half a tennis ball at the injection site.
The first dose activated the shingles virus and I had a very bad time with fever, itching and a lot of burning on the left side of the neck and shoulder. The second dose gave me a fever, pain all over my body, and a red rash all over my neck, shoulders and arms. on the left side of the neck a small lump appeared as a swelling of the lymph nodes.
I coudnt attend 2nd dose on June 18; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I coudnt attend 2nd dose on June 18) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I coudnt attend 2nd dose on June 18). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I coudnt attend 2nd dose on June 18) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was unknown.
I premise that I have no idea if what happened to me can be related to the vaccine. Exactly 4 weeks from the second shot, I woke up and within one hour I started losing my hearing at my left ear. The problem was progressively getting worse. I saw my family doctor the next day and she recommended some product for ear wax and she suggested to see a ENT doctor if the problem persisted. The problem not only persisted but the next day I totally lost my hearing at my left ear. I was able to see a ENT doctor the next day and they assessed a 97% loss of my hearing. I have been diagnosed with a sudden sensorineural  hearing loss (SSHL). The doctor prescribed Prednisone 60mg for 4 days and then tapered down to 20 mg for 10 days. I have recovered 98% of my hearing in almost 4 weeks. I still have some noise and very slight tinnitus. One thing I should add is that I have history of hyper reaction to vaccines, for example swollen lymph nodes for up to 4 weeks after taking flu shots. Since the SSHL can be related to autoimmune reaction, this may be a connection. I have done different exams, including imaging (MRI) to exclude any other issue that may cause this hearing loss.
Fever of 99. 6 the morning after the shot, in the afternoon it went up to 100.1 and stayed that way until morning of 1/27/2021, chills, fatigue, night sweats, no appetite, achy, wheezing at night, coughing
Irritated around the vaccine area applied, a lot of itchy and when I touch fell like a cellulitis.
Describe Event, Problem, or Product Use Error: not feeling well, aches, fever after COVID-19 vaccine booster (Moderna)
Pt recv vax on 3/22/99; on 4/1/99 pt exp swollen/ rash/ tender lump at vax site; tx=antihistamine
1 hour after administration of vaccine 0.3ml  the staff member began to have a systemic blotching on skin and dry, severe cough.
Myalgia, Fever, NauseaVomiting, pt w/ c/o chills, fatigue, ecchymosis at injection site (1.5 x 2cm) Narrative: pt w/ complaints of symptoms same day after receiving both vaccinations. . pt reports missing 2 days of work after second injection. sx occured immediately after being vaccinated. patient reported experiencing symptoms after receiving 1st vaccine however reported them with sx endured from 2nd vaccination.
Woke up 6/23/17 with swollen hands and feet, especially fingers. "Looks like he gained 10 pounds." Denies any SOB/dyspnea. Sites where vaccines were administered were without redness or local swelling. Left arm (where 2 vaccines were administered) had increased swelling than the right. Doctor ordered BENADRYL, CLARITIN, and Ranitidine. Symptoms resolved and then 2 days later developed bumps on his face which resolved after swimming.
reflux; chest pain; stomach is upset; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (reflux), VACCINATION SITE PAIN (sore arm), CHEST PAIN (chest pain) and ABDOMINAL DISCOMFORT (stomach is upset) in a 68-year-old female patient who received mRNA-1273 (batch no. 002B21A) for COVID-19 vaccination.     The patient's past medical history included Reflux gastritis. Concomitant products included MAGNESIUM OXIDE HEAVY, SODIUM BICARBONATE (ANTACID C).   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form.   On 10-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore arm).   On an unknown date, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (reflux), CHEST PAIN (chest pain) and ABDOMINAL DISCOMFORT (stomach is upset). At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (reflux), VACCINATION SITE PAIN (sore arm), CHEST PAIN (chest pain) and ABDOMINAL DISCOMFORT (stomach is upset) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Intramuscular) was unknown.  Most recent FOLLOW-UP information incorporated above includes: On 18-Mar-2021: Significant Follow up appended